Avesthagen specializes in the discovery, development and marketing of quality ingredients aimed at degenerative conditions that combine nature, tradition and technology.
In addition to a well-defined development cycle, Avesthagen also offers the following technology advantages as part of its "Natural Products" platform:
Over 3,000 formulations described in traditional medicine compendia like Ayurveda, Unani or Siddha compendia classified by disease states. They have been developed empirically over several thousand years, and there is demonstrated evidence that several of them have passed extensive pre-clinical and clinical validation. This is
our primary source for lead selection.
Listing of more than 2,500 medicinal plants with extensive
information about their ethno-botanical uses and
pharmacognosy used to validate selected leads.
Listing of the molecular structure and profiles of more than
15,000 compounds common to plants reported to have
biological activity across disease states. Combined with a
proprietary molecular profiling technology called MetaGridTM,
it also contains additional biological and chemical analysis
of the potential leads.